Erschienen in:
01.02.2010
Can Antihypertensive Treatment Reverse Large-Artery Stiffening?
verfasst von:
Michel E. Safar
Erschienen in:
Current Hypertension Reports
|
Ausgabe 1/2010
Einloggen, um Zugang zu erhalten
Abstract
In some controlled therapeutic trials for hypertension, a selective reduction of systolic blood pressure has been obtained with long-term treatment. The greatest effects on cardiovascular outcomes stem from a decrease of central blood pressure through a significant reduction of arterial stiffness, wave reflections, or both. Until now, all protocols have used angiotensin II blockade, mainly through angiotensin-converting enzyme inhibition. Cardiovascular outcomes have been significantly improved when compared with controls, but most of them have been treated with beta blockers. Such “de-stiffening” therapies are important to consider and require additional trials.